Skip to main content

Verastem Inc

For the period ended May 23, 2024. Filed Apr 12, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

May 23, 2024 · Filed Apr 12, 2024

Use the contents to explore the available documents and sections.

VSTM$8.41-10.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Potential Dilution

The following table provides information regarding the number of shares subject to each type of outstanding award under the 2021 Plan (inclusive of the May 2023 Amended and Restated 2021 Plan) and the 2012 Plan, the number of shares of our common stock available for future awards under the May 2023 Amended and Restated 2021 Plan, the number of additional shares that would be available for future awards under the Amended and Restated 2021 Plan, if approved by stockholders, and the dilutive impact of each to our stockholders as of March 22, 2024. As of March 22, 2024, there were no longer any outstanding awards under our 2010 Equity Incentive Plan.

​​​​​
​​​​As a percentage of
​​Number of​stock outstanding
​ · ​ · Shares · as of March 22, 2024
Outstanding stock options1,918,339​7.6%
Outstanding restricted stock units421,788​1.7%
Total shares subject to outstanding awards under the May 2023 Amended and Restated 2021 Plan and the 2012 Plan​2,340,127​9.2%
Total shares available for future awards under the May 2023 Amended and Restated 2021 Plan​492,047​1.9%
Total shares subject to outstanding awards under the May 2023 Amended and Restated 2021 Plan and the 2012 Plan or available for future awards under the May 2023 Amended and Restated 2021 Plan​2,832,174​11.2%
Proposed additional shares available for future awards under the Amended and Restated 2021 Plan​3,200,000​12.6%
Total potential dilution​6,032,174​23.8%

As indicated by the numbers in the table above, as of March 22, 2024, the date on which the Board of Directors adopted the Amended and Restated 2021 Plan, the potential dilution under the May 2023 Amended and Restated 2021 Plan, and the 2012 Plan was 11.2%. If the Amended and Restated 2021 Plan is approved by our stockholders, our potential dilution will be 23.8%.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.